1
|
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.
|
Nature
|
2008
|
8.22
|
2
|
Adaptive immunity maintains occult cancer in an equilibrium state.
|
Nature
|
2007
|
8.14
|
3
|
Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.
|
Immunity
|
2013
|
3.51
|
4
|
IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia.
|
Nat Immunol
|
2012
|
2.62
|
5
|
Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.
|
Immunity
|
2010
|
2.56
|
6
|
Cancer immunoediting by the innate immune system in the absence of adaptive immunity.
|
J Exp Med
|
2012
|
1.93
|
7
|
Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin.
|
Nat Immunol
|
2009
|
1.88
|
8
|
Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells.
|
J Exp Med
|
2009
|
1.67
|
9
|
G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms.
|
Blood
|
2007
|
1.66
|
10
|
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
|
Breast Cancer Res
|
2012
|
1.56
|
11
|
Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice.
|
J Clin Invest
|
2004
|
1.47
|
12
|
ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice.
|
J Thorac Oncol
|
2015
|
1.42
|
13
|
Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo.
|
J Exp Med
|
2011
|
1.39
|
14
|
Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival.
|
Blood
|
2005
|
1.36
|
15
|
A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha.
|
Blood
|
2003
|
1.35
|
16
|
AIRE deficiency in thymus of 2 patients with Omenn syndrome.
|
J Clin Invest
|
2005
|
1.35
|
17
|
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity.
|
Proc Natl Acad Sci U S A
|
2009
|
1.34
|
18
|
Trafficking properties of plasmacytoid dendritic cells in health and disease.
|
Trends Immunol
|
2010
|
1.24
|
19
|
Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.
|
Eur J Immunol
|
2003
|
1.22
|
20
|
Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice.
|
EMBO J
|
2004
|
1.21
|
21
|
Innate immunity defects in Hermansky-Pudlak type 2 syndrome.
|
Blood
|
2006
|
1.19
|
22
|
The plasmacytoid monocyte/interferon producing cells.
|
Virchows Arch
|
2003
|
1.13
|
23
|
Recruitment of dendritic cells in oral lichen planus.
|
J Pathol
|
2005
|
1.10
|
24
|
A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC.
|
Eur J Immunol
|
2009
|
1.09
|
25
|
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3.
|
Blood
|
2010
|
1.05
|
26
|
Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases.
|
Head Neck
|
2012
|
1.05
|
27
|
RNA sensor-induced type I IFN prevents diabetes caused by a β cell-tropic virus in mice.
|
J Clin Invest
|
2011
|
1.04
|
28
|
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.
|
Eur J Immunol
|
2012
|
1.03
|
29
|
Functional defects of dendritic cells in patients with CD40 deficiency.
|
Blood
|
2003
|
1.02
|
30
|
Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
|
J Exp Med
|
2013
|
1.00
|
31
|
Nonredundant role of CCRL2 in lung dendritic cell trafficking.
|
Blood
|
2010
|
0.98
|
32
|
Adhesion of human T cells to antigen-presenting cells through SIRPbeta2-CD47 interaction costimulates T-cell proliferation.
|
Blood
|
2004
|
0.96
|
33
|
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.
|
Blood
|
2012
|
0.95
|
34
|
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma.
|
Blood
|
2011
|
0.94
|
35
|
Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
|
Exp Dermatol
|
2007
|
0.93
|
36
|
Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients.
|
Blood
|
2010
|
0.92
|
37
|
Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs.
|
J Allergy Clin Immunol
|
2010
|
0.92
|
38
|
Activin A induces Langerhans cell differentiation in vitro and in human skin explants.
|
PLoS One
|
2008
|
0.91
|
39
|
Thymus microenvironment in human primary immunodeficiency diseases.
|
Curr Opin Allergy Clin Immunol
|
2009
|
0.91
|
40
|
Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cells.
|
J Immunol
|
2014
|
0.90
|
41
|
Defective migration of monocyte-derived dendritic cells in LAD-1 immunodeficiency.
|
J Leukoc Biol
|
2002
|
0.90
|
42
|
Characterization of the immune cell repertoire in the normal fallopian tube.
|
Int J Gynecol Pathol
|
2014
|
0.88
|
43
|
Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection.
|
Eur J Immunol
|
2010
|
0.86
|
44
|
Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
|
J Pathol
|
2013
|
0.86
|
45
|
The Emerging Role of NRAS Mutations in Colorectal Cancer Patients Selected for Anti-EGFR Therapies.
|
Rev Recent Clin Trials
|
2014
|
0.85
|
46
|
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues.
|
Int Immunol
|
2009
|
0.84
|
47
|
Melanoma immunoediting by NK cells.
|
Oncoimmunology
|
2012
|
0.84
|
48
|
On the potential involvement of CD11d in co-stimulating the production of interferon-γ by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3.
|
Haematologica
|
2011
|
0.83
|
49
|
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.
|
Mol Cancer Ther
|
2013
|
0.82
|
50
|
The Muir-Torre syndrome: a typical case of misdiagnosis and consequent worsened prognosis.
|
Int J Colorectal Dis
|
2014
|
0.81
|
51
|
BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells.
|
Blood
|
2013
|
0.81
|
52
|
Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages.
|
Blood
|
2006
|
0.80
|
53
|
Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: variability of CD56 and granzyme B expression.
|
Am J Surg Pathol
|
2003
|
0.79
|
54
|
Central nervous system marginal zone B-cell lymphoma associated with Chlamydophila psittaci infection.
|
Hum Pathol
|
2011
|
0.78
|
55
|
Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old.
|
BMC Surg
|
2014
|
0.77
|
56
|
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.
|
PLoS One
|
2013
|
0.77
|
57
|
Intralymphatic atypical T-cell proliferation in a cutaneous hemangioma.
|
J Cutan Pathol
|
2009
|
0.75
|
58
|
Correction: slanDCs/M-DC8+ cells constitute a distinct subset of dendritic cells in human tonsils.
|
Oncotarget
|
2016
|
0.75
|
59
|
Pseudolymphomatous luetic lymphadenitis associated with B cell clonality.
|
Virchows Arch
|
2012
|
0.75
|
60
|
Correction: Dual Function of CD70 in Viral Infection: Modulator of Early Cytokine Responses and Activator of Adaptive Responses.
|
J Immunol
|
2015
|
0.75
|